These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19386019)

  • 1. Off-label use in dermatology in Germany: what has changed since 2004.
    Brockmeyer NH; Brucklacher U; Potthoff A; Reich-Schupke S
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):938-45. PubMed ID: 19386019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Off-label-use in dermatology].
    Sterry W
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):931-2. PubMed ID: 19909390
    [No Abstract]   [Full Text] [Related]  

  • 3. Off-label uses of biologic agents in dermatology: a 2006 update.
    Kerns MJ; Graves JE; Smith DI; Heffernan MP
    Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key opinion leaders: where they come from and how that affects the drugs you prescribe.
    Meffert JJ
    Dermatol Ther; 2009; 22(3):262-8. PubMed ID: 19453351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Appropriate off-label prescription in practice].
    Augustin M
    Hautarzt; 2013 Oct; 64(10):728-35. PubMed ID: 24150820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative uses of rituximab in dermatology.
    Carr DR; Heffernan MP
    Dermatol Clin; 2010 Jul; 28(3):547-57. PubMed ID: 20510764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Panorama of dermatologic practice].
    Hautarzt; 2011 May; 62(5):321-3. PubMed ID: 21541832
    [No Abstract]   [Full Text] [Related]  

  • 8. [Off-label use in dermatological practice. The conflict between professional duty and legal requirements].
    Brunne V; Mertins G; Reimann G; Brockmeyer NH
    Hautarzt; 2004 Aug; 55(8):727-34. PubMed ID: 15241515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rise of the generic drug market and its implications for dermatology.
    Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New indications for Hyaluronic acid of the NASHA-gel-generation--highlights from aesthetical dermatology in clinical daily routine].
    Becker-Wegerich P
    J Dtsch Dermatol Ges; 2008 Dec; 6 Suppl 3():S3-20. PubMed ID: 19138284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Off-label use and G-BA. Legal framework for off-label use].
    Brucklacher U; Brockmeyer NH; Riedel C
    Hautarzt; 2013 Oct; 64(10):736-42. PubMed ID: 24150821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Panorama of dermatologic practice].
    Hautarzt; 2008 Jan; 59(1):5-9. PubMed ID: 18217172
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in on and off-label calcipotriene use.
    Pearce DJ; Camacho F; Balkrishnan R; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2006; 17(5):308-13. PubMed ID: 17092863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dermatology in an exciting decade].
    Luger T; Stadler R
    J Dtsch Dermatol Ges; 2011 Mar; 9(3):177-8, 180. PubMed ID: 21352478
    [No Abstract]   [Full Text] [Related]  

  • 15. Off-label medication use in an academic hospital pediatric critical care unit.
    Hsu B; Brazelton T
    WMJ; 2009 Oct; 108(7):343-8. PubMed ID: 19886581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment off-label prescribing in Dermatology].
    Picard D; Carvalho P; Bonnavia C; Louin L; Josset V; Lauret P; Joly P;
    Ann Dermatol Venereol; 2003 May; 130(5):507-10. PubMed ID: 12843825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
    Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
    Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Austrian Society for Dermatology and Venereology OGDV].
    J Dtsch Dermatol Ges; 2009 Sep; 7(9):820. PubMed ID: 19712234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Off-label use: update and relevance for urology].
    Krege S; Rohde D
    Aktuelle Urol; 2007 Jul; 38(4):301-4. PubMed ID: 17647167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in dermatologic therapy.
    Thiers BH
    Dermatol Ther; 2008; 21(2):142-9. PubMed ID: 18394088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.